Novavax vaccine shows resilient defense against symptomatic COVID-19 despite Omicron challenge

Recent study assesses NVX-CoV2373 vaccine’s effectiveness against Omicron variant. Findings show decreased efficacy over four months, but stable protection against symptomatic COVID-19.

AbbVie bets $48M upfront for early-stage antibody targeting chronic inflammation

AbbVie is making good on its plans to search for new mechanisms of action, this time with French biotech OSE Immunotherapeutics for a monoclonal antibody

February 29, 2024

Nurse Community Mourns ‘Trailblazer’ Claire Fagin, PhD, RN

Claire Fagin, PhD, RN, a nurse scientist, advocate, innovator, and one of the first women to lead an Ivy League university, died on January 16

February 7, 2024

Unlocking Value-Based Care Through Accurate Provider Data

Eric Demers, CEO of Madaket Health There’s no better illustration of the healthcare system’s data problems than this: 80% of entries in the nation’s five

December 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.